The follow-up evaluation method of the implementation of WHO “Access to Essential Medicines” resolution: a systematic review_Chinese Journal of Evidence-Based Medicine

Authors：

LIN Mao ^1,2,3,4 ^# , JIANG Lucan ^1,2,3,4 ^# , ZENG Linan ^1,2,3 , ZHANG Yang ^1,2,3 , GUI Ge ^1,2,3,4 ,  ZHANG Lingli ^1,2,3

1. Department of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu, 610041, P.R.China;
2. Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu, 610041, P.R.China;
3. Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, 610041, P.R.China;
4. West China School of Pharmacy, Sichuan University, Chengdu, 610041, P.R.China;

Corresponding?author：

ZHANG Lingli, Email: zhanglingli@scu.edu.cn

Keywords：

World health organization; World health assembly; Resolution; Essential medicine; Accessibility; Assessment method; Indicator

DOI：

10.7507/1672-2531.201810085

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objectives To construct a follow-up evaluation indicator system on the implementation of the WHO resolution of " Access to essential medicines” by systematic review, and to provide a methodological support for tracking the implementation of the resolution, with a view to providing evidence of decision-making to promote the accessibility of essential medicines and further promote and improve the national essential medicine policy. It also provides a methodological reference for investigating the implementation of other public health sector resolutions.Methods PubMed, EMbase, The Cochrane Library, Web of Science, CBM, WanFang Data and CNKI databases and relevant international or national official websites of pharmaceutical administration department or academic organization were searched to collect studies on accessibility of WHO essential drugs from inception to February, 2016. Two researchers independently screened literature, extracted data, and qualitative analysis was used to sort out and screen the evaluation indicators for the implementation of the WHO resolution of "Access to essential medicines".Results A total of 60 relevant literatures, three guides and 19 progress reports of the World Health Assembly from official websites were included. Through the screening of indicators, we could get two parts: the indicators of measures to implement the resolution and the indicators of the results of the implementation of the resolution.Conclusions This study analyzes the implementation of the resolution of the health system in the progress report of the World Health Assembly 2013–2015, divides the implementation of the resolution into two parts: the implementation of the resolution and the results of the implementation of the resolution. An indicator system for establishing measures and evaluation the resolution has been found. Expert consultations will be further developed to establish the final indicators for the implementation of the "Access to essential medicines".

Citation： LIN Mao, JIANG Lucan, ZENG Linan, ZHANG Yang, GUI Ge, ZHANG Lingli. The follow-up evaluation method of the implementation of WHO “Access to Essential Medicines” resolution: a systematic review. Chinese Journal of Evidence-Based Medicine, 2019, 19(4): 471-480. doi: 10.7507/1672-2531.201810085 Copy

1.	World Health Organization. How to develop and implement a national drug policy (2 Edition). Available at: http://apps.who.int/medicinedocs/en/d/Js2283e/4.1.2.html.
2.	World Health Organization. Health topic: essential medicines. Available at: http://www.who.int/topics/essential_medicines/en/.
3.	World Health Organization. 2013-2020年預防和控制慢性非傳染性疾病行動計劃. Available at: http://apps.who.int/gb/ebwha/pdf_files/WHA66/A66_9-ch.pdf.
4.	World Health Organization. Improving access to essential medicines in the Western Pacific region. Available at: http://www.wpro.who.int/NR/rdonlyres/588F3CB4-22F9-4543-A65E-BB447D8425AA/0/Regional_Strategy_for_Improving_Access.pdf.
5.	World Health Assembly. Access to essential medicine (WHA 67.22). Available at: http://apps.who.int/gb/ebwha/pdf_files/WHA67-REC1/A67_2014_REC1-ch.pdf#page=25.
6.	Anson A, Ramay B, de Esparza AR, et al. Availability, prices and affordability of the World Health Organization's essential medicines for children in Guatemala. Global Health, 2012, 8(1): 22-31.
7.	Babar ZU, Ibrahim MI, Singh H, et al. Evaluating drug prices, availability, affordability, and price components: implications for access to drugs in Malaysia. PLoS Med, 2007, 4(3): e82.
8.	Babar ZU, Lessing C, Mace C, et al. The availability, pricing and affordability of three essential asthma medicines in 52 low- and middle-income countries. Pharmacoeconomics, 2013, 31(11): 1063-1082.
9.	Balasubramaniam R, Benaragama BV, Sri Ranganathan S. A national survey of price and affordability of key essential medicines for children in Sri Lanka. Indian J Pediatr, 2014, 81(4): 362-367.
10.	Andréa DB, Helfer AP, Camargo AL, et al. Is the Brazilian pharmaceutical policy ensuring population access to essential medicines? Global Health, 2012, 8(1): 6-16.
11.	Jiang M, Zhou Z, Wu L, et al. Medicine prices, availability, and affordability in the Shanxi province in China: implications for the future. Int J Clin Pharm, 2015, 37(1): 12-17.
12.	Cameron A, Bansal A, Dua T, et al. Mapping the availability, price, and affordability of antiepileptic drugs in 46 countries. Epilepsia, 2012, 53(6): 962-969.
13.	Kotwani A, Ewen M, Dey D, et al. Prices & availability of common medicines at six sites in India using a standard methodology. Indian J Med Res, 2007, 125(5): 645-654.
14.	Kotwani A. Availability, price and affordability of asthma medicines in five Indian states. Int J Tuberc Lung Dis, 2009, 13(5): 574-579.
15.	Chahal HS, St Fort N, Bero L. Availability, prices and affordability of essential medicines in Haiti. J Glob Health, 2013, 3(2): 020405.
16.	Mhlanga BS, Suleman F. Price, availability and affordability of medicines. Afr J Prim Health Care Fam Med, 2014, 6(1): E1-E6.
17.	Cheraghali AM, Idries AM. Availability, affordability, and prescribing pattern of medicines in Sudan. Pharm World Sci, 2009, 31(2): 209-215.
18.	Wang X, Fang Y, Yang S, et al. Access to paediatric essential medicines: a survey of prices, availability, affordability and price components in Shaanxi Province, China. PLoS One, 2014, 9(3): e90365.
19.	Dabare PRL, Wanigatunge CA, Beneragama BH. A national survey on availability, price and affordability of selected essential medicines for noncommunicable diseases in Sri Lanka. BMC Public Health, 2014, 14: 817-827.
20.	Senarathna SM, Mannapperuma U, Fernandopulle BM. Medicine prices, availability and affordability in Sri Lanka. Indian J Pharmacol, 2011, 43(1): 60-63.
21.	Carasso BS, Lagarde M, Tesfaye A, et al. Availability of essential medicines in Ethiopia: an efficiency-equity trade-off? Trop Med Int Health, 2009, 14(11): 1394-1400.
22.	陳高潔, 席曉宇, 褚淑貞. 基于藥師的角度對基本藥物可及性情況的KAP調查. 中國藥事, 2011, 25(8): 755-757.
23.	陳瑤, 代濤, 白冰. 安徽省基本藥物可及性實證研究. 北京: 中國醫學科學院/北京協和醫學院醫學信息研究所/圖書館學術年會, 2013.
24.	陳瑤, 白冰, 代濤. 安徽省基層醫療衛生機構基本藥物制度實施效果. 中國衛生政策研究, 2013, 6(4): 31-35.
25.	代濤, 黃紅霞, 梅遂章, 等. 河南省基層醫療衛生機構基本藥物制度實施效果. 中國衛生政策研究, 2013, 6(4): 36-40.
26.	代濤, 白冰, 陳瑤. 基本藥物制度實施效果評價研究綜述. 中國衛生政策研究, 2013, 6(4): 12-18.
27.	管曉東, 信梟雄, 劉洋, 等. 我國基本藥物可負擔性評價實證研究. 中國藥房, 2013, (24): 2220-2224.
28.	管曉東, 李晗, 劉洋, 等. 我國基本藥物價格水平實證研究. 中國藥房, 2013, (24): 2224-2228.
29.	楊肖光, 朱曉麗, 代濤. 北京市昌平區社區衛生服務中心基本藥物制度實施效果的評價. 首都食品與醫藥, 2015, (16): 13-15.
30.	虎翼. 寧夏基本藥物可及度指標性評價研究. 銀川: 寧夏醫科大學, 2014.
31.	黃勇. 基于患者角度的我國基本藥物行為可及性研究. 中國醫藥指南, 2013, (22): 721-723.
32.	姜明歡, 方宇, 王文娟, 等. 陜西省公立醫院和零售藥店基本藥物價格及可獲得性比較研究. 2012年中國藥學會藥事管理專業委員會年會暨" 十二五”醫藥科學發展學術研討會論文集(下冊), 2012.
33.	姜明歡, 周忠良, 方宇, 等. 陜西省零售藥店藥品價格與可獲得性評估研究. 中國衛生政策研究, 2013, 6(8): 37-42.
34.	姜明歡, 王樂, 王文娟, 等. 陜西省公立醫院基本藥物制度實施狀況評估. 中華醫院管理雜志, 2013, 29(5): 347-352.
35.	李鋒. 廣州市社區衛生服務機構基本藥物可獲得性調查. 中國衛生經濟, 2011, 30(8): 52-54.
36.	李萍, 陽昊, 張新平. 湖北省農村醫療機構和零售藥店基本藥物價格調查. 醫學與社會, 2010, 23(10): 51-53.
37.	李萍, 呂景睿, 陽昊, 等. 湖北省農村居民基本藥物可負擔性研究. 醫學與社會, 2010, 23(2): 18-20.
38.	李顯文, 章燕麗, 吳森林, 等. 實施基本藥物制度后基層的藥品可及性調查. 衛生經濟研究, 2012, (6): 24-26.
39.	李顯文, 章燕麗, 吳森林. 基本藥物制度下藥品費用可負擔性實證分析. 中國農村衛生事業管理, 2013, 33(1): 10-13.
40.	林騰飛, 胡明, 吳佳怡. 四川省農村基層醫療機構基本藥物制度實施效果研究. 中國衛生政策研究, 2013, 6(10): 48-53.
41.	劉慧, 張曉萌. 宣教干預對基本藥物心理可及性的影響調查. 赤峰學院學報(自然科學版), 2014, (8): 49-50.
42.	馬金華, 席曉宇, 褚淑貞. 基于患者的角度對基本藥物可及性情況的知識-態度-行為調查分析. 中國新藥雜志, 2012, (18): 2109-2112.
43.	宋燕, 卞鷹. 浙江省基層醫療機構基本藥物制度實施效果的綜合評價. 中國衛生政策研究, 2011, 4(10): 43-47.
44.	宋燕, 卞鷹. 基本藥物制度對提高中國農村地區藥品可及性的實證分析. 北京: 中國衛生政策研究論壇, 2012.
45.	唐紹貴, 侯天宇, 趙茜, 等. 山西省某縣級醫療衛生機構基本藥物價格水平與可負擔性研究. 中國藥房, 2014, (24): 2223-2226.
46.	王芳, 丁雪, 代濤. 重慶市基層醫療衛生機構基本藥物制度實施效果. 中國衛生政策研究, 2013, 6(4): 41-46.
47.	王力, 孫希望, 余蘇珍, 等. 江西省農村居民基本藥物可及性調查與分析. 中國衛生經濟, 2012, 31(12): 62-63.
48.	王力, 余蘇珍, 陳和利, 等. 江西省農村地區基本藥物可獲得性情況分析. 衛生經濟研究, 2013, (2): 30-31.
49.	王瀟, 楊世民, 方宇, 等. 基于WHO/HAI標準化法的陜西省零售藥店兒童基本藥物價格及供應研究. 2013年中國藥學會藥事管理專業委員會年會暨" 醫藥安全與科學發展”學術論壇論文集(下冊), 2013.
50.	劉璐, 方宇, 姜明歡, 等. 西安市縣級公立醫院實行藥品零差率的補償機制研究. 中國藥業, 2013, 22(12): 1-2.
51.	魏艷, 尹文強, 范海平, 等. 基于熵權灰色關聯法的鄉鎮衛生院基本藥物可獲得性研究. 中國衛生經濟, 2014, 33(8): 70-72.
52.	吳紅雁, 潘嵐嵐, 陳磊. WHO/HAI標準調查法對部分國家與地區基本藥物的可獲得性研究. 中國藥房, 2015, (9): 1153-1156.
53.	席曉宇, 馬金華, 褚淑貞. 基于醫務工作者的基本藥物可及性KAP調查. 藥品評價, 2011, 8(12): 16-20.
54.	席曉宇, 徐丹妮. 基于文獻研究視角的基本藥物可及性問題研究. 藥品評價, 2012, 9(8): 6-12.
55.	徐偉, 殷丹妮. 江蘇省基本藥物可負擔性實證研究. 上海醫藥, 2012, 33(3): 43-47.
56.	徐偉, 殷丹妮. 我國基本藥物可負擔性實證研究. 中國藥房, 2012, (40): 3745-3747.
57.	徐偉, 李靜. 江蘇省基本藥物可獲得性實證研究. 中國藥房, 2013, (8): 676-679.
58.	陽昊, 李萍, 張新平. 湖北省孝感市農村地區基本藥物可獲得性研究. 中國藥房, 2008, 19(29): 2244-2247.
59.	陽昊. 湖北省農村地區縣鄉兩級基本藥物可獲得性研究. 武漢: 華中科技大學, 2009.
60.	楊慧云. 山東省農村地區基本藥物的可及性研究. 濟南: 山東大學, 2012.
61.	楊顯輝. 我國基本藥物制度評估指標體系研究. 鄭州: 河南大學, 2012.
62.	葉露, 胡善聯, Margaret E, et al. 上海市基本藥物可負擔性實證研究. 中國衛生資源, 2008, 11(4): 195-196.
63.	張新平, 鄭雙江, 田昕. 社區衛生服務機構基本藥物可獲得性研究. 中國衛生政策研究, 2010, 3(6): 14-17.
64.	張瑩芳, 常育. 我國西部地區部分省市的基本藥物可負擔性實證研究. 中國醫藥指南, 2013, (3): 676-677.
65.	張悅, 羅加詳, 虎翼, 等. 寧夏基本藥物可及性評價指標體系的建立. 衛生軟科學, 2015, (1): 1-4.
66.	World Health Organization. Indicators for monitoring national drug policies (2nd Edition). Available at: http://apps.who.int/bookorders/anglais/detart1.jsp?sesslan=1&codlan=1&codcol=93&codcch=2066.
67.	World Health Organization/Health Action International. Measuring medicine prices, availability, affordability and price components (2nd Edition). Available at: http://www.who.int/medicines/areas/access/medicines_prices08/en/index.html.
68.	World Health Organization. How to investigate drug use in health facilities. Available at: http://apps.who.int/medicinedocs/en/d/Js2289e/.
69.	World Health Organization. Fifty-sixth world health assembly-WHO medicines strategy: progress report. Available at: http://apps.who.int/gb/archive/pdf_files/WHA56/ea5616.pdf.
70.	World Health Organization. Fifty-Seventh World Health Assembly-Implementation of resolutions (progress reports). Available at: http://apps.who.int/gb/archive/pdf_files/WHA57/A57_18-en.pdf.
71.	World Health Organization. Fifty-Seventh World Health Assembly-Road safety and health: update. Available at: http://apps.who.int/gb/archive/pdf_files/WHA57/A57_10Add1-en.pdf.
72.	World Health Organization. Fifty-Eighth World Health Assembly-International Plan of Action on Ageing: report on implementation. Available at: http://apps.who.int/gb/archive/pdf_files/WHA58/A58_19-en.pdf.
73.	World Health Organization. Fifty-Eighth World Health Assembly-Implementation of resolutions (progress reports) WHO Framework Convention on Tobacco Control. Available at: http://apps.who.int/gb/archive/pdf_files/WHA58/A58_23Add1-en.pdf.
74.	World Health Organization. Fifty-Eighth World Health Assembly-Implementation of resolutions (progress reports). Available at: http://apps.who.int/gb/archive/pdf_files/WHA58/A58_23-en.pdf.
75.	World Health Organization. Fifty-Ninth World Health Assembly-Implementation of resolutions (progress reports). Available at: http://apps.who.int/gb/archive/pdf_files/WHA59/A59_23-en.pdf.
76.	World Health Organization. Fifty-Ninth World Health Assembly-Health conditions in the occupied Palestinian territory, including east Jerusalem, and in the occupied Syrian Golan: progress report. Available at: http://apps.who.int/gb/archive/pdf_files/WHA59/A59_24-en.pdf.
77.	World Health Organization. Sixtieth World Health Assembly-Progress reports on technical and health matters. Available at: http://apps.who.int/gb/archive/pdf_files/WHA60/A60_28-en.pdf.
78.	World Health Organization. Sixty-First World Health Assembly- Progress reports on technical and health matters. Available at: http://apps.who.int/gb/archive/pdf_files/A61/A61_17-en.pdf.
79.	World Health Organization. Sixty-First World Health Assembly- Progress reports on technical and health matters. Available at: http://apps.who.int/gb/archive/pdf_files/A61/A61_17Add1-en.pdf.
80.	World Health Organization. Sixty-Second World Health Assembly-Progress reports. Available at: http://apps.who.int/gb/ebwha/pdf_files/A62/A62_23-en.pdf.
81.	World Health Organization. Sixty-Third World Health Assembly-Progress reports. Available at: http://apps.who.int/gb/ebwha/pdf_files/WHA63/A63_27-en.pdf.
82.	World Health Organization. Sixty-Fourth World Health Assembly-Progress reports. Available at: http://apps.who.int/gb/ebwha/pdf_files/WHA64/A64_26-en.pdf.
83.	World Health Organization. Sixty-Fifth World Health Assembly-Progress reports. Available at: http://apps.who.int/gb/ebwha/pdf_files/WHA65/A65_26-en.pdf.
84.	World Health Organization. Sixty-Sixth World Health Assembly-Progress reports. Available at: http://apps.who.int/gb/ebwha/pdf_files/WHA66/A66_27Add1-en.pdf.
85.	World Health Organization. Sixty-Sixth World Health Assembly-Progress reports. Available at: http://apps.who.int/gb/ebwha/pdf_files/WHA66/A66_27-en.pdf.
86.	World Health Organization. Sixty-Seventh World Health Assembly-Progress reports. Available at: http://apps.who.int/gb/ebwha/pdf_files/WHA67/A67_40-en.pdf.
87.	World Health Organization. Sixty-Eighth World Health Assembly-Progress reports. Available at: http://apps.who.int/gb/ebwha/pdf_files/WHA68/A68_36-en.pdf.
88.	World Health Assembly. WHO medicines strategy. Available at: http://apps.who.int/gb/archive/pdf_files/WHA54/ea54r11.pdf. 99, 104, 105, 111, 112, 116-118.
89.	World Health Assembly. Social determinants of health: outcome of the World Conference on Social Determinants of Health. Available at: http://apps.who.int/gb/ebwha/pdf_files/WHA65/A65_16-en.pdf.
90.	World Health Assembly. Availability, safety and quality of blood products. Available at: http://apps.who.int/gb/e/e_wha63.html.
91.	World Health Assembly. Human organ and tissue transplantation. Available at: http://apps.who.int/gb/ebwha/pdf_files/WHA63/A63_24-en.pdf.
92.	World Health Assembly. Report of the Intergovernmental Working Group on Public Health, Innovation and Intellectual Property. Available at: https://www.who.int/mediacentre/events/2008/wha61/issues_paper1/en/.
93.	World Health Assembly. Quality of care: patient safety. Available at: http://apps.who.int/gb/archive/pdf_files/WHA55/ewha5518.pdf.
94.	World Health Assembly. Workers’ health: draft global plan of action. Available at: http://apps.who.int/gb/archive/pdf_files/WHA60/A60_20-en.pdf.
95.	World Health Assembly. Integrating gender analysis and actions into the work of WHO: draft strategy. Available at: http://apps.who.int/gb/archive/pdf_files/WHA60/A60_19-en.pdf.
96.	World Health Assembly. Progress in the rational use of medicines. Available at: http://apps.who.int/gb/archive/pdf_files/WHA60/A60_24-en.pdf.
97.	中華人民共和國衛生部等九部委. 關于建立國家基本藥物制度的實施意見. Available at: http://www.sda.gov.cn/WS01/CL0056/40753.html.

1. World Health Organization. How to develop and implement a national drug policy (2 Edition). Available at: http://apps.who.int/medicinedocs/en/d/Js2283e/4.1.2.html.
2. World Health Organization. Health topic: essential medicines. Available at: http://www.who.int/topics/essential_medicines/en/.
3. World Health Organization. 2013-2020年預防和控制慢性非傳染性疾病行動計劃. Available at: http://apps.who.int/gb/ebwha/pdf_files/WHA66/A66_9-ch.pdf.
4. World Health Organization. Improving access to essential medicines in the Western Pacific region. Available at: http://www.wpro.who.int/NR/rdonlyres/588F3CB4-22F9-4543-A65E-BB447D8425AA/0/Regional_Strategy_for_Improving_Access.pdf.
5. World Health Assembly. Access to essential medicine (WHA 67.22). Available at: http://apps.who.int/gb/ebwha/pdf_files/WHA67-REC1/A67_2014_REC1-ch.pdf#page=25.
6. Anson A, Ramay B, de Esparza AR, et al. Availability, prices and affordability of the World Health Organization's essential medicines for children in Guatemala. Global Health, 2012, 8(1): 22-31.
7. Babar ZU, Ibrahim MI, Singh H, et al. Evaluating drug prices, availability, affordability, and price components: implications for access to drugs in Malaysia. PLoS Med, 2007, 4(3): e82.
8. Babar ZU, Lessing C, Mace C, et al. The availability, pricing and affordability of three essential asthma medicines in 52 low- and middle-income countries. Pharmacoeconomics, 2013, 31(11): 1063-1082.
9. Balasubramaniam R, Benaragama BV, Sri Ranganathan S. A national survey of price and affordability of key essential medicines for children in Sri Lanka. Indian J Pediatr, 2014, 81(4): 362-367.
10. Andréa DB, Helfer AP, Camargo AL, et al. Is the Brazilian pharmaceutical policy ensuring population access to essential medicines? Global Health, 2012, 8(1): 6-16.
11. Jiang M, Zhou Z, Wu L, et al. Medicine prices, availability, and affordability in the Shanxi province in China: implications for the future. Int J Clin Pharm, 2015, 37(1): 12-17.
12. Cameron A, Bansal A, Dua T, et al. Mapping the availability, price, and affordability of antiepileptic drugs in 46 countries. Epilepsia, 2012, 53(6): 962-969.
13. Kotwani A, Ewen M, Dey D, et al. Prices & availability of common medicines at six sites in India using a standard methodology. Indian J Med Res, 2007, 125(5): 645-654.
14. Kotwani A. Availability, price and affordability of asthma medicines in five Indian states. Int J Tuberc Lung Dis, 2009, 13(5): 574-579.
15. Chahal HS, St Fort N, Bero L. Availability, prices and affordability of essential medicines in Haiti. J Glob Health, 2013, 3(2): 020405.
16. Mhlanga BS, Suleman F. Price, availability and affordability of medicines. Afr J Prim Health Care Fam Med, 2014, 6(1): E1-E6.
17. Cheraghali AM, Idries AM. Availability, affordability, and prescribing pattern of medicines in Sudan. Pharm World Sci, 2009, 31(2): 209-215.
18. Wang X, Fang Y, Yang S, et al. Access to paediatric essential medicines: a survey of prices, availability, affordability and price components in Shaanxi Province, China. PLoS One, 2014, 9(3): e90365.
19. Dabare PRL, Wanigatunge CA, Beneragama BH. A national survey on availability, price and affordability of selected essential medicines for noncommunicable diseases in Sri Lanka. BMC Public Health, 2014, 14: 817-827.
20. Senarathna SM, Mannapperuma U, Fernandopulle BM. Medicine prices, availability and affordability in Sri Lanka. Indian J Pharmacol, 2011, 43(1): 60-63.
21. Carasso BS, Lagarde M, Tesfaye A, et al. Availability of essential medicines in Ethiopia: an efficiency-equity trade-off? Trop Med Int Health, 2009, 14(11): 1394-1400.
22. 陳高潔, 席曉宇, 褚淑貞. 基于藥師的角度對基本藥物可及性情況的KAP調查. 中國藥事, 2011, 25(8): 755-757.
23. 陳瑤, 代濤, 白冰. 安徽省基本藥物可及性實證研究. 北京: 中國醫學科學院/北京協和醫學院醫學信息研究所/圖書館學術年會, 2013.
24. 陳瑤, 白冰, 代濤. 安徽省基層醫療衛生機構基本藥物制度實施效果. 中國衛生政策研究, 2013, 6(4): 31-35.
25. 代濤, 黃紅霞, 梅遂章, 等. 河南省基層醫療衛生機構基本藥物制度實施效果. 中國衛生政策研究, 2013, 6(4): 36-40.
26. 代濤, 白冰, 陳瑤. 基本藥物制度實施效果評價研究綜述. 中國衛生政策研究, 2013, 6(4): 12-18.
27. 管曉東, 信梟雄, 劉洋, 等. 我國基本藥物可負擔性評價實證研究. 中國藥房, 2013, (24): 2220-2224.
28. 管曉東, 李晗, 劉洋, 等. 我國基本藥物價格水平實證研究. 中國藥房, 2013, (24): 2224-2228.
29. 楊肖光, 朱曉麗, 代濤. 北京市昌平區社區衛生服務中心基本藥物制度實施效果的評價. 首都食品與醫藥, 2015, (16): 13-15.
30. 虎翼. 寧夏基本藥物可及度指標性評價研究. 銀川: 寧夏醫科大學, 2014.
31. 黃勇. 基于患者角度的我國基本藥物行為可及性研究. 中國醫藥指南, 2013, (22): 721-723.
32. 姜明歡, 方宇, 王文娟, 等. 陜西省公立醫院和零售藥店基本藥物價格及可獲得性比較研究. 2012年中國藥學會藥事管理專業委員會年會暨" 十二五”醫藥科學發展學術研討會論文集(下冊), 2012.
33. 姜明歡, 周忠良, 方宇, 等. 陜西省零售藥店藥品價格與可獲得性評估研究. 中國衛生政策研究, 2013, 6(8): 37-42.
34. 姜明歡, 王樂, 王文娟, 等. 陜西省公立醫院基本藥物制度實施狀況評估. 中華醫院管理雜志, 2013, 29(5): 347-352.
35. 李鋒. 廣州市社區衛生服務機構基本藥物可獲得性調查. 中國衛生經濟, 2011, 30(8): 52-54.
36. 李萍, 陽昊, 張新平. 湖北省農村醫療機構和零售藥店基本藥物價格調查. 醫學與社會, 2010, 23(10): 51-53.
37. 李萍, 呂景睿, 陽昊, 等. 湖北省農村居民基本藥物可負擔性研究. 醫學與社會, 2010, 23(2): 18-20.
38. 李顯文, 章燕麗, 吳森林, 等. 實施基本藥物制度后基層的藥品可及性調查. 衛生經濟研究, 2012, (6): 24-26.
39. 李顯文, 章燕麗, 吳森林. 基本藥物制度下藥品費用可負擔性實證分析. 中國農村衛生事業管理, 2013, 33(1): 10-13.
40. 林騰飛, 胡明, 吳佳怡. 四川省農村基層醫療機構基本藥物制度實施效果研究. 中國衛生政策研究, 2013, 6(10): 48-53.
41. 劉慧, 張曉萌. 宣教干預對基本藥物心理可及性的影響調查. 赤峰學院學報(自然科學版), 2014, (8): 49-50.
42. 馬金華, 席曉宇, 褚淑貞. 基于患者的角度對基本藥物可及性情況的知識-態度-行為調查分析. 中國新藥雜志, 2012, (18): 2109-2112.
43. 宋燕, 卞鷹. 浙江省基層醫療機構基本藥物制度實施效果的綜合評價. 中國衛生政策研究, 2011, 4(10): 43-47.
44. 宋燕, 卞鷹. 基本藥物制度對提高中國農村地區藥品可及性的實證分析. 北京: 中國衛生政策研究論壇, 2012.
45. 唐紹貴, 侯天宇, 趙茜, 等. 山西省某縣級醫療衛生機構基本藥物價格水平與可負擔性研究. 中國藥房, 2014, (24): 2223-2226.
46. 王芳, 丁雪, 代濤. 重慶市基層醫療衛生機構基本藥物制度實施效果. 中國衛生政策研究, 2013, 6(4): 41-46.
47. 王力, 孫希望, 余蘇珍, 等. 江西省農村居民基本藥物可及性調查與分析. 中國衛生經濟, 2012, 31(12): 62-63.
48. 王力, 余蘇珍, 陳和利, 等. 江西省農村地區基本藥物可獲得性情況分析. 衛生經濟研究, 2013, (2): 30-31.
49. 王瀟, 楊世民, 方宇, 等. 基于WHO/HAI標準化法的陜西省零售藥店兒童基本藥物價格及供應研究. 2013年中國藥學會藥事管理專業委員會年會暨" 醫藥安全與科學發展”學術論壇論文集(下冊), 2013.
50. 劉璐, 方宇, 姜明歡, 等. 西安市縣級公立醫院實行藥品零差率的補償機制研究. 中國藥業, 2013, 22(12): 1-2.
51. 魏艷, 尹文強, 范海平, 等. 基于熵權灰色關聯法的鄉鎮衛生院基本藥物可獲得性研究. 中國衛生經濟, 2014, 33(8): 70-72.
52. 吳紅雁, 潘嵐嵐, 陳磊. WHO/HAI標準調查法對部分國家與地區基本藥物的可獲得性研究. 中國藥房, 2015, (9): 1153-1156.
53. 席曉宇, 馬金華, 褚淑貞. 基于醫務工作者的基本藥物可及性KAP調查. 藥品評價, 2011, 8(12): 16-20.
54. 席曉宇, 徐丹妮. 基于文獻研究視角的基本藥物可及性問題研究. 藥品評價, 2012, 9(8): 6-12.
55. 徐偉, 殷丹妮. 江蘇省基本藥物可負擔性實證研究. 上海醫藥, 2012, 33(3): 43-47.
56. 徐偉, 殷丹妮. 我國基本藥物可負擔性實證研究. 中國藥房, 2012, (40): 3745-3747.
57. 徐偉, 李靜. 江蘇省基本藥物可獲得性實證研究. 中國藥房, 2013, (8): 676-679.
58. 陽昊, 李萍, 張新平. 湖北省孝感市農村地區基本藥物可獲得性研究. 中國藥房, 2008, 19(29): 2244-2247.
59. 陽昊. 湖北省農村地區縣鄉兩級基本藥物可獲得性研究. 武漢: 華中科技大學, 2009.
60. 楊慧云. 山東省農村地區基本藥物的可及性研究. 濟南: 山東大學, 2012.
61. 楊顯輝. 我國基本藥物制度評估指標體系研究. 鄭州: 河南大學, 2012.
62. 葉露, 胡善聯, Margaret E, et al. 上海市基本藥物可負擔性實證研究. 中國衛生資源, 2008, 11(4): 195-196.
63. 張新平, 鄭雙江, 田昕. 社區衛生服務機構基本藥物可獲得性研究. 中國衛生政策研究, 2010, 3(6): 14-17.
64. 張瑩芳, 常育. 我國西部地區部分省市的基本藥物可負擔性實證研究. 中國醫藥指南, 2013, (3): 676-677.
65. 張悅, 羅加詳, 虎翼, 等. 寧夏基本藥物可及性評價指標體系的建立. 衛生軟科學, 2015, (1): 1-4.
66. World Health Organization. Indicators for monitoring national drug policies (2nd Edition). Available at: http://apps.who.int/bookorders/anglais/detart1.jsp?sesslan=1&codlan=1&codcol=93&codcch=2066.
67. World Health Organization/Health Action International. Measuring medicine prices, availability, affordability and price components (2nd Edition). Available at: http://www.who.int/medicines/areas/access/medicines_prices08/en/index.html.
68. World Health Organization. How to investigate drug use in health facilities. Available at: http://apps.who.int/medicinedocs/en/d/Js2289e/.
69. World Health Organization. Fifty-sixth world health assembly-WHO medicines strategy: progress report. Available at: http://apps.who.int/gb/archive/pdf_files/WHA56/ea5616.pdf.
70. World Health Organization. Fifty-Seventh World Health Assembly-Implementation of resolutions (progress reports). Available at: http://apps.who.int/gb/archive/pdf_files/WHA57/A57_18-en.pdf.
71. World Health Organization. Fifty-Seventh World Health Assembly-Road safety and health: update. Available at: http://apps.who.int/gb/archive/pdf_files/WHA57/A57_10Add1-en.pdf.
72. World Health Organization. Fifty-Eighth World Health Assembly-International Plan of Action on Ageing: report on implementation. Available at: http://apps.who.int/gb/archive/pdf_files/WHA58/A58_19-en.pdf.
73. World Health Organization. Fifty-Eighth World Health Assembly-Implementation of resolutions (progress reports) WHO Framework Convention on Tobacco Control. Available at: http://apps.who.int/gb/archive/pdf_files/WHA58/A58_23Add1-en.pdf.
74. World Health Organization. Fifty-Eighth World Health Assembly-Implementation of resolutions (progress reports). Available at: http://apps.who.int/gb/archive/pdf_files/WHA58/A58_23-en.pdf.
75. World Health Organization. Fifty-Ninth World Health Assembly-Implementation of resolutions (progress reports). Available at: http://apps.who.int/gb/archive/pdf_files/WHA59/A59_23-en.pdf.
76. World Health Organization. Fifty-Ninth World Health Assembly-Health conditions in the occupied Palestinian territory, including east Jerusalem, and in the occupied Syrian Golan: progress report. Available at: http://apps.who.int/gb/archive/pdf_files/WHA59/A59_24-en.pdf.
77. World Health Organization. Sixtieth World Health Assembly-Progress reports on technical and health matters. Available at: http://apps.who.int/gb/archive/pdf_files/WHA60/A60_28-en.pdf.
78. World Health Organization. Sixty-First World Health Assembly- Progress reports on technical and health matters. Available at: http://apps.who.int/gb/archive/pdf_files/A61/A61_17-en.pdf.
79. World Health Organization. Sixty-First World Health Assembly- Progress reports on technical and health matters. Available at: http://apps.who.int/gb/archive/pdf_files/A61/A61_17Add1-en.pdf.
80. World Health Organization. Sixty-Second World Health Assembly-Progress reports. Available at: http://apps.who.int/gb/ebwha/pdf_files/A62/A62_23-en.pdf.
81. World Health Organization. Sixty-Third World Health Assembly-Progress reports. Available at: http://apps.who.int/gb/ebwha/pdf_files/WHA63/A63_27-en.pdf.
82. World Health Organization. Sixty-Fourth World Health Assembly-Progress reports. Available at: http://apps.who.int/gb/ebwha/pdf_files/WHA64/A64_26-en.pdf.
83. World Health Organization. Sixty-Fifth World Health Assembly-Progress reports. Available at: http://apps.who.int/gb/ebwha/pdf_files/WHA65/A65_26-en.pdf.
84. World Health Organization. Sixty-Sixth World Health Assembly-Progress reports. Available at: http://apps.who.int/gb/ebwha/pdf_files/WHA66/A66_27Add1-en.pdf.
85. World Health Organization. Sixty-Sixth World Health Assembly-Progress reports. Available at: http://apps.who.int/gb/ebwha/pdf_files/WHA66/A66_27-en.pdf.
86. World Health Organization. Sixty-Seventh World Health Assembly-Progress reports. Available at: http://apps.who.int/gb/ebwha/pdf_files/WHA67/A67_40-en.pdf.
87. World Health Organization. Sixty-Eighth World Health Assembly-Progress reports. Available at: http://apps.who.int/gb/ebwha/pdf_files/WHA68/A68_36-en.pdf.
88. World Health Assembly. WHO medicines strategy. Available at: http://apps.who.int/gb/archive/pdf_files/WHA54/ea54r11.pdf. 99, 104, 105, 111, 112, 116-118.
89. World Health Assembly. Social determinants of health: outcome of the World Conference on Social Determinants of Health. Available at: http://apps.who.int/gb/ebwha/pdf_files/WHA65/A65_16-en.pdf.
90. World Health Assembly. Availability, safety and quality of blood products. Available at: http://apps.who.int/gb/e/e_wha63.html.
91. World Health Assembly. Human organ and tissue transplantation. Available at: http://apps.who.int/gb/ebwha/pdf_files/WHA63/A63_24-en.pdf.
92. World Health Assembly. Report of the Intergovernmental Working Group on Public Health, Innovation and Intellectual Property. Available at: https://www.who.int/mediacentre/events/2008/wha61/issues_paper1/en/.
93. World Health Assembly. Quality of care: patient safety. Available at: http://apps.who.int/gb/archive/pdf_files/WHA55/ewha5518.pdf.
94. World Health Assembly. Workers’ health: draft global plan of action. Available at: http://apps.who.int/gb/archive/pdf_files/WHA60/A60_20-en.pdf.
95. World Health Assembly. Integrating gender analysis and actions into the work of WHO: draft strategy. Available at: http://apps.who.int/gb/archive/pdf_files/WHA60/A60_19-en.pdf.
96. World Health Assembly. Progress in the rational use of medicines. Available at: http://apps.who.int/gb/archive/pdf_files/WHA60/A60_24-en.pdf.
97. 中華人民共和國衛生部等九部委. 關于建立國家基本藥物制度的實施意見. Available at: http://www.sda.gov.cn/WS01/CL0056/40753.html.

Chinese Journal of Evidence-Based Medicine

The follow-up evaluation method of the implementation of WHO “Access to Essential Medicines” resolution: a systematic review

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content